4.7 Article Proceedings Paper

Is it time for in silico simulation of drug cardiac side effects?

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk

Gary R. Mirams et al.

CARDIOVASCULAR RESEARCH (2011)

Article Pharmacology & Pharmacy

Novel Approaches to Assessing Cardiac Safety – Proceedings of a Workshop

Katherine Fletcher et al.

DRUG SAFETY (2011)

Review Biochemistry & Molecular Biology

High-throughput functional curation of cellular electrophysiology models

Jonathan Cooper et al.

PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2011)

Review Pharmacology & Pharmacy

An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing risk

C. E. Pollard et al.

BRITISH JOURNAL OF PHARMACOLOGY (2010)

Review Multidisciplinary Sciences

Arrhythmic risk biomarkers for the assessment of drug cardiotoxicity: from experiments to computer simulations

A. Corrias et al.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2010)

Article Computer Science, Interdisciplinary Applications

Chaste: A test-driven approach to software development for biological modelling

Joe Pitt-Francis et al.

COMPUTER PHYSICS COMMUNICATIONS (2009)

Article Cardiac & Cardiovascular Systems

Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death

SMJM Straus et al.

EUROPEAN HEART JOURNAL (2005)

Article Multidisciplinary Sciences

Models of cardiac ventricular action potentials: iterative interaction between experiment and simulation

D Noble et al.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2001)